spantide I

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2016
01219912016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
RATIONALE Although we and others have recently shown that mast cells play an important role in plaque progression and… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2008
2008
PURPOSE Studies have shown that blocking substance P (SP) binding to neurokinin 1 receptor with spantide I prevents Pseudomonas… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
2007
2007
PURPOSE To determine the effects of blocking substance P (SP) interactions with its major receptor (NK1-R) using the antagonist… (More)
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
2007
2007
BACKGROUND Acute cutaneous neurogenic inflammation initiated by activation of transient receptor potential vanilloid-1 (TRPV1… (More)
  • figure 7
Is this relevant?
2005
2005
Neurokinin receptors (NK1, NK2, NK3) are G-protein-coupled receptors, which upon activation by a peptide agonist induce a… (More)
Is this relevant?
2005
2005
Studies have shown that after Pseudomonas aeruginosa (P. aeruginosa) corneal infection, BALB/c mice that are capable of resolving… (More)
Is this relevant?
2001
2001
The bioluminescent Ca2+-sensitive reporter protein, aequorin, was employed to develop an insect cell-based functional assay… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2000
2000
OBJECTIVE To study and evaluate the effects of perfusion through cerebral ventricles with substance P (SP) and its analogs… (More)
Is this relevant?
1991
1991
We compared the ability of spantide I and II to antagonize tachykinins in monoreceptor bioassays. Both peptides antagonized the… (More)
Is this relevant?
1991
1991
CP-96,345, a quinuclidine, is a potent inhibitor of substance P for the NK1 receptor of bovine brain, but has reduced potency for… (More)
Is this relevant?